HR 719
117th Congress
House
Health
Cardiovascular and respiratory health
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Health technology, devices, supplies
Infectious and parasitic diseases
Medical tests and diagnostic methods
State and local government operations
Right to Test Act
Introduced: February 2, 2021
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 3, 2021
Referred to the Subcommittee on Health.
Feb 2, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Introduced in House
Plain-English summary
Right to Test Act
This bill authorizes a state's public health department, or another entity designated by the state's governor, to approve a diagnostic test or diagnostic device (e.g., a test for the virus that causes COVID-19, or coronavirus disease 2019) for use during a public health emergency.
Unless requested by the governor of the state, the Food and Drug Administration (FDA) must not, during the emergency, engage in certain enforcement actions related to such a test or device.
Not later than 180 days following the end of the public health emergency, the FDA must review and make a final determination concerning approval of the test or device.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2